首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 通訊 > RFID > 醫療・藥品市場中RFID的活用:2009年至2019年s
產業/市場分類
通訊 (11029)
企業概況 (728)
光纖網路 (252)
次世代無線通信 (543)
行動用戶 (134)
行動設備 (736)
軟體 (997)
電子商務 (202)
網路 (626)
網路與進入設備 (257)
數位廣播 (307)
數據中心 (342)
寬頻 (389)
衛星遠程通信 (134)
線上廣告 (143)
整合 (197)
整合通訊 (293)
機上盒 (63)
聯繫中心 (130)
Contents (606)
IT安全性 (474)
IT委外 (302)
LBS (149)
NFC (149)
RFID (246)
Web服務 (463)
WLAN/WiMAX (558)
市場調查報告書

醫療・藥品市場中RFID的活用:2009年至2019年s

RFID for Healthcare and Pharmaceuticals 2009-2019

出版商 IDTechEx Ltd.
出版日期 2009年08月 商品編碼 96329
內容資訊 英文 290 Pages Tables 45+ Figures 100+
價格
US $ 2895 Web Access (Five User License)
US $ 3150 Web Access (Five User License) & Hard Copy


醫療・藥品市場中RFID的活用:2009年至2019年s 是由出版商IDTechEx Ltd.在2009年08月所出版的。 這份英文市場調查報告書包含290 Pages Tables 45+ Figures 100+ 價格從美金2895起跳。

簡介

本報告書內容包括:醫療・藥品市場中RFID的利用動向調查分析、目的別各種應用、全球主要利用事例個案研究、2019年之前的市場成長預測、主要供應商介紹。內容綱要摘記如下:

第1章 介紹

  • 醫療・藥品市場的課題
  • 無線電頻率識別
  • RTLS(即時定位資訊系統)
  • 頻率動向
  • 穩私權問題

第2章 員工・訪客・患者・固定資產的定位資訊及狀況

  • 課題
  • RTLS的最大優點
  • 醫療市場中RTLS的需求・顧慮・障礙的詳細介紹
  • RTLS技術
  • 技術選擇
  • 供應商
  • RTLS個案研究:人類室内定位資訊系統
  • RTLS個案研究:資產及供應

第3章 防偽藥・防竊盗・追蹤

  • 課題
  • 法律專家・產業意見
  • 個案研究
  • 供應商的能力

第4章 減少疏失・處理記錄・患者的順應情形

  • 減少疏失・處理記錄
  • 患者的順應情形
  • 個案研究

第5章 血液・供應・設備管理

  • 血液檢查・輸送・輸血
  • 智慧櫥櫃
  • 洗衣店:出租用紡織品
  • 文件管理
  • 助聽器
  • 個案研究
  • 供應商的能力

第6章 醫療市場中RFID的利用情形:其他

  • 安全連線
  • 事故記錄及警示
  • 個案研究

第7章 市場的未來預測

  • 整體RFID市場:2009年至2019年
  • 醫療・藥品市場的RFID市場:2009年至2019年
  • RTLS市場:2009年至2019年

附錄

圖表

目錄

Abstract

“The market for RFID tags and systems in healthcare will be $94.6 million in 2009”

Description

The RFID business is growing so fast that few applicational sectors can beat that scorching rate of growth. Healthcare and pharmaceuticals is one of them thanks to the new tagging of drugs, real time location of staff and patients and other developments including automated error prevention. This unique report gives a full technical and market analysis illustrated by 70 case studies. It is a vital resource for the healthcare profession and all who wish to support it. We separately assess the opportunity for both passive and active tags in pharmaceuticals and healthcare in the following sectors:

  • Pharmaceutial drugs
  • Medical disposables and other items
  • Pallets and cases
  • Laundry
  • People
  • Secure Access
  • Conveyances, vehicles, assets
  • Real Time Locating Systems (RTLS)
  • Sensor based applications

RFID in healthcare and pharmaceuticals has special requirements, unquantifiable benefits (safety, security, reputation, brand protection etc) and sometimes tolerance of longer paybacks for such reasons can often lead to very profitable and worthwhile business for suppliers. Extensive benchmarking in the business leads to rapid dissemination of the multiple benefits to users of given schemes and great pressure on the laggards to catch up.

Table of Contents

EXECUTIVE SUMMARY AND CONCLUSIONS

1. INTRODUCTION

  • 1.1. Relevant challenges in healthcare and pharmaceuticals
  • 1.2. Radio Frequency Identification
  • 1.3. Real Time Locating Systems
  • 1.4. Trend of frequencies
    • 1.4.1. Form of Active RFID
    • 1.4.2. Radio regulations are changing
    • 1.4.3. No ideal frequency for everything
    • 1.4.4. Ultra Wide Band (UWB)
  • 1.5. Privacy issues

2. LOCATION AND STATUS OF STAFF, VISITORS, PATIENTS AND FIXED ASSETS

  • 2.1. Challenges
  • 2.2. Primary benefits of RTLS
  • 2.3. Detailed needs, concerns, impediments for RTLS in healthcare
  • 2.4. RTLS technology
    • 2.4.1. Definition of RTLS
  • 2.5. Choice of technologies
    • 2.5.1. Radianse view of technologies
    • 2.5.2. Zonal
    • 2.5.3. Radio fingerprinting
    • 2.5.4. Triangulation and Time Difference of Arrival (TDOA)
    • 2.5.5. Global Positioning System (GPS)
    • 2.5.6. Received Signal Strength Indication (RSSI)
    • 2.5.7. GSM and GPRS
  • 2.6. Suppliers
  • 2.7. RTLS Case studies: Indoor Positioning Systems for people
    • 2.7.1. IPS in hospitals
    • 2.7.2. Nagoya Ekisaikai Hospital Japan
    • 2.7.3. Alexandra Hospital/ Singapore National University Hospital, Singapore
    • 2.7.4. Mercy Hospital USA
    • 2.7.5. Brigham & Women' s Hospital, USA
    • 2.7.6. Borgess Medical Center patients USA
    • 2.7.7. City halls Japan
    • 2.7.8. Saarbrucken Clinic Germany
    • 2.7.9. Presbyterian Hospital USA
    • 2.7.10. Changgen Memorial Hospital Taiwan
    • 2.7.11. Tung Yuan Hospital in Hsinchu, Taiwan
    • 2.7.12. Hospitals Israel
    • 2.7.13. Werribee Mercy Hospital, Australia
    • 2.7.14. Wirral Hospital UK
    • 2.7.15. Birmingham Heartlands and Solihull NHS Trust UK
    • 2.7.16. Academic Medical Centre The Netherlands
    • 2.7.17. Sun Yat-Sen Cancer Center Taiwan
    • 2.7.18. Lancaster General Hospital USA
    • 2.7.19. Bangkok Hospital Thailand
  • 2.8. RTLS case studies - assets and supplies
    • 2.8.1. Jackson Memorial Hospital USA
    • 2.8.2. Beth Israel Deaconess Medical Center USA
    • 2.8.3. Bon Secours Health System, USA
    • 2.8.4. Salmon Creek Hospital USA
    • 2.8.5. Vanderbilt Children' s Hospital USA
    • 2.8.6. Washington Hospital Center, USA
    • 2.8.7. Hospital of the University of Pennsylvania USA
    • 2.8.8. Legacy Health System USA
    • 2.8.9. Good Shepherd Hospital USA
    • 2.8.10. Palmetto Health USA
    • 2.8.11. Holy Name Hospital USA
    • 2.8.12. Catholic Medical Center - KangNam St. Mary' s Hospital, patients and staff Korea
    • 2.8.13. Bronson Healthcare Group, patients and staff USA
    • 2.8.14. Nottingham University Hospitals NHS Trust assets UK

3. PHARMACEUTICAL ANTICOUNTERFEITING, THEFT CONTROL AND TRACKING

  • 3.1. Challenges
    • 3.1.1. Solutions to counterfeit pharmaceuticals
  • 3.2. Attitude of legislators and the industry
    • 3.2.1. Food and Drug Administration USA
    • 3.2.2. FDA U-turn
    • 3.2.3. Actual FDA progress to 2009
    • 3.2.4. European Pharmaceutical Industry
    • 3.2.5. East Asia
    • 3.2.6. Case study Wal-Mart mandate for Type 2 pharmaceuticals
    • 3.2.7. Leadership from Pfizer and other major suppliers
    • 3.2.8. Pharmaceutical theft reduction and tracking
  • 3.3. Case studies
    • 3.3.1. Pfizer Viagra USA
    • 3.3.2. GlaxoSmithKline Trizivir drug item level USA
    • 3.3.3. Abbott Laboratories Wal-Mart USA
    • 3.3.4. Cephalon, tracking pharmaceuticals, France, Germany, UK, USA
    • 3.3.5. CVS Pharmacy USA
    • 3.3.6. Felletti Spadazzi Italy
    • 3.3.7. GS1 Europe
    • 3.3.8. HD Smith USA
    • 3.3.9. Johnson & Johnson USA
    • 3.3.10. McKesson USA
    • 3.3.11. Millennium Pharmaceutical UK
    • 3.3.12. Novartis USA
    • 3.3.13. Purdue Pharma USA
    • 3.3.14. Ranbaxy Pharmaceuticals India
    • 3.3.15. UK Pharmaceutical UK
    • 3.3.16. Unimed Pharma Korea
    • 3.3.17. Walgreens USA
    • 3.3.18. West Pharmaceutical Services USA
    • 3.3.19. Cardinal Health USA
    • 3.3.20. Felletti Spadazzi, drug cases, Italy
  • 3.4. Suppliers capabilities

4. ERROR REDUCTION, RECORDING PROCEDURES, PATIENT COMPLIANCE

  • 4.1. Error reduction and recording procedures
    • 4.1.1. Electronic handshake to prevent mismatching of patient to treatment
    • 4.1.2. Human implants for instant medical record of high risk patients
  • 4.2. Patient compliance
    • 4.2.2. Bang & Olufsen Medicaid, Denmark
    • 4.2.3. Precision Dynamics, USA
    • 4.2.4. Brenmoor UK
    • 4.2.5. Stora Enso
  • 4.3. Case studies
    • 4.3.1. Fischer Clinical Services drug trials item level, USA
    • 4.3.2. Melexis, Belgium
    • 4.3.3. AstraZeneca, UK
    • 4.3.4. Baptist Health USA
    • 4.3.5. Veterans V/A Hospitals USA
    • 4.3.6. Regenesis Biomedical USA
    • 4.3.7. Mediplus, UK
    • 4.3.8. South Tyneside Healthcare Trust UK

5. MANAGEMENT OF BLOOD, SUPPLIES, EQUIPMENT

  • 5.1. Blood testing, transport and transfusion
  • 5.2. Smart cabinets
    • 5.2.1. Electrolux, Germany
  • 5.3. Laundry - rented textiles
  • 5.4. Document management
    • 5.4.1. Uchida Yoko, Japan
    • 5.4.2. Yoshikawa, Japan
  • 5.5. Hearing aids
  • 5.6. Case studies
    • 5.6.1. Massachusetts General Hospital, blood USA
    • 5.6.2. Portsmouth General Hospital, blood UK
    • 5.6.3. Georgetown University Hospital, blood USA
    • 5.6.4. Saarbrucken Clinic, blood Germany
    • 5.6.5. St James Hospital Ireland
    • 5.6.6. Medline Industries, surgical disposables, USA
  • 5.7. Supplier capability
    • 5.7.1. Hitachi, Japan
    • 5.7.2. DHL healthcare logistics Europe

6. OTHER USES FOR RFID IN HEALTHCARE

  • 6.1. Secure access
  • 6.2. Recording and alerting to incidents
  • 6.3. Case studies
    • 6.3.1. NHS Security Management Service, staff safety UK
    • 6.3.2. Hospital La Conception, pathology samples France
    • 6.3.3. Human Fertilisation and Embryology Authority (HFEA), embryos, eggs, sperm UK
    • 6.3.4. Paoli Calmette Institute, pathology samples Italy
    • 6.3.5. Hart District Council, safety of disabled at home UK

7. MARKET FORECASTS

  • 7.1. Total RFID market 2009-2019
  • 7.2. Healthcare and pharmaceutical RFID market 2009-2019
    • 7.2.2. Potential for RFID on prescription drugs
  • 7.3. RTLS market 2009-2019

APPENDIX 1: IDTECHEX PUBLICATIONS AND RESEARCH

APPENDIX 2: CONTACT DETAILS

APPENDIX 3: INTRODUCTION TO RFID

APPENDIX 4: RFID SOLUTION PROVIDERS

TABLES

  • 1.1. Some of the relevant challenges in healthcare and pharmaceuticals and how RFID can help
  • 1.2. Some tasks performed by RFID
  • 1.3. The commonly used licence free frequencies for active RFID
  • 2.1. Examples of needs and concerns about RTLS in healthcare
  • 2.2. Wherify view of RTLS options
  • 2.3. Comparison of today' s favourite RTLS systems in healthcare
  • 2.4. Examples of companies with RTLS systems or appropriate parts and services
  • 2.5. Examples of suppliers and developers of RTLS systems
  • 2.6. Required characteristics of an indoor positioning solution
  • 2.7. Equipment Rental Costs: Financial Results
  • 2.8. Associate Satisfaction: Nursing Satisfaction Scores
  • 3.1. Some of the leading suppliers and aspiring suppliers of RFID labels for pharmaceuticals.
  • 4.1. Telemetry technologies available and their drawbacks for patient monitoring
  • 6.1. Comparison of the two types of RFID smart card
  • 6.2. Comparison of RFID shoes, wristbands and implants for secure access
  • 7.1. Assumptions for forecasts of healthcare and pharmaceuticals RFID market 2009-2019
  • 7.2. Passive tags number million sold globally for healthcare and pharmaceuticals 2009-2019
  • 7.3. Passive tags for healthcare and pharmaceuticals unit price cents 2009-2019
  • 7.4. Passive tags for healthcare and pharmaceuticals value dollar millions 2009-2019
  • 7.5. Active tags for healthcare and pharmaceuticals number million 2009-2019
  • 7.6. Active tags for healthcare and pharmaceuticals unit price cents 2009-2019
  • 7.7. Active tags for healthcare and pharmaceuticals value dollars millions 2009-2019
  • 7.8. Chipless percentage share of the overall RFID market by numbers 2009 to 2019. Projection by IDTechEx
  • 7.9. Addressable market in billions yearly as a function of tag price

FIGURES

  • 1.1. Technical performance for active RFID in crowded environments as a function of frequency in the view of Savi Technology
  • 1.2. UWB frequency spread compared with some alternative active RFID bands in the microwave region
  • 2.1. Radianse view of the relative merits of some RTLS technologies
  • 2.2. Example of Zonal RTLS
  • 2.3. A typical business case for parasitic WiFi over conventional RTLS. An increasing proportion of hospitals seem to be convinced enough to buy such a radio fingerprinting solution.
  • 2.4. How does the system work?
  • 2.5. Ekahau WiFi tag
  • 2.6. Monitoring system for personnel tags
  • 2.7. Zonal personnel tracking system
  • 2.8. Using RFID to guide people
  • 2.9. Miyake white navigation system
  • 2.10. Verichip Hugs and Kisses tags for mother baby matching
  • 2.11. Hospital contact history and monitoring system
  • 2.12. Overall strategic design
  • 2.13. Patient track & alarm
  • 2.14. Information systems in Wirral Hospital
  • 2.15. Analysis - EDR/EIS
  • 2.16. Radianse RTLS tags
  • 2.17. A selection of UWB RFID tags
  • 2.18. GSH equipment rental costs
  • 2.19. GSH equipment purchasing costs
  • 2.20. GSH associate satisfaction
  • 2.21. HealthCare pilot RTLS tags
  • 2.22. How The HealthCare Pilot system works
  • 3.1. The TAGSYS stamp sized HF RFID label fitted to all US shipments of Pfizer Viagra
  • 3.2. Short and Long Term Anticounterfeiting Strategies
  • 3.3. Avery Dennison UHF smart label for item level drugs
  • 3.4. 915 MHz EPC tag on item level drugs packages from Abbott Laboratories in the Accenture trials. The EPC code was only printed on the outside for the first phase (see bottom of label).
  • 4.1. Usage and background data is read from the device and logged
  • 4.2. Luer connectors in ' wrong' configuration
  • 4.3. Luer connectors in ' correct' configurations
  • 4.4. Traceability / medical devices in a manufacturer/distributor
  • 4.5. Traceability / medical devices within a hospital situation
  • 4.6. Level of non-compliance for different medical treatments
  • 4.7. Patient compliance blisterpack from Information Mediary Canada
  • 4.8. Precision Dynamics RFID wristband
  • 4.9. What is Smart Band?
  • 4.10. Hospital architecture model
  • 4.11. Patient information data pipeline
  • 4.12. Smart Band solutions at work through the complete patient care process
  • 4.13. On-the-fly calibration - just show the bottom of the container to the glucometer
  • 4.14. Glucometer application in detail - the MLX90109 reader
  • 4.15. Glucometer application in detail - the MLX90127 sticky label transponder
  • 4.16. Diprivan TCI tag construction
  • 4.17. Tagged syringe and Diprifusor™
  • 4.18. Pill bottle with smart label (printed prescription label not shown)
  • 4.19. ScripTalk speaker
  • 4.20. Mediplus tagged catheter
  • 4.21. Mediplus Pressflow overview
  • 5.1. Uchida Yoko' s ' Pick up by light' system
  • 5.2. Tag with LED - File by Light system. The LED is in the top left corner
  • 5.3. Applying Coil-on-Chip to hearing aids
  • 5.4. Square CoC tag chip enclosed in protective plastic coating
  • 5.5. How the intelliaid™ system works
  • 5.6. Intelliaid™ scanners
  • 5.7. Paling Risk Scale for major transfusion hazards
  • 5.8. SHOT project: cumulative data 1996 to 2001
  • 5.9. Increasing errors within hospitals
  • 5.10. Safe transfusion: Processes not just product
  • 5.11. Automated warning generated when a possible mis-match of blood and patient occurs
  • 5.12. RFID on blood container, next to interrogator
  • 5.13. Blood labelled with RFID chip
  • 5.14. The process - blood sampling
  • 5.15. The process - pathology laboratory
  • 5.16. The benefits - supporting change
  • 5.17. Identifying patients and their blood
  • 5.18. Hitachi CoC blood donor card
  • 5.19. The card is flexible
  • 5.20. CoC tags as cards or tokens shown in interrogators
  • 5.21. Hitachi tagged test tube
  • 5.22. Hitachi multihead antenna array, a form of ' smart shelf'
  • 5.23. TAGSYS item level HF label
  • 5.24. DHL in the healthcare supply chain
  • 5.25. DHL RFID Pilot Experience & Development Areas
  • 6.1. Principle of Miyake foot key system for secure access by staff
  • 6.2. Principle of Miyake foot key system for control of disoriented elderly
  • 6.3. Hospital staff with the Connexion2 alarm/ record device
  • 6.4. The reverse of the Connexion2 device showing the button that activates remote recording
  • 6.5. HF tags from TAGSYS
  • 6.6. Alarm button on the active RFID pendant
  • 7.1. Passive tags number million sold globally for healthcare and pharmaceuticals 2009-2019
  • 7.2. Passive tags for healthcare and pharmaceuticals unit price cents 2009-2019
  • 7.3. Passive tags for healthcare and pharmaceuticals value dollar millions 2009-2019
  • 7.4. Active tags for healthcare and pharmaceuticals number million 2009-2019
  • 7.5. Active tags for healthcare and pharmaceuticals unit price cents 2009-2019
  • 7.6. Active tags for healthcare and pharmaceuticals value dollars millions 2009-2019
  • 7.7. RTLS as a percentage of the active RFID market in 2009 by value
  • 7.8. RTLS as a percentage of the active RFID market in 2019 by value
Back to Top